XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Founders Preferred Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income Loss
Treasury Stock
Accumulated Deficit
Series A Convertible Preferred Stock
Series X Convertible Preferred Stock
Class A Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Class B Common Stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2018             0 0        
Beginning balance at Dec. 31, 2018             $ 0 $ 0        
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Conversion of SAFE into Series A convertible preferred stock for cash, net of issuance costs (in shares)             68,877,417          
Conversion of SAFE into Series A convertible preferred stock for cash, net of issuance costs of $3,775             $ 169,951          
Conversion of debt into Series A convertible preferred stock (in shares)             4,326,514          
Conversion of debt into Series A convertible preferred stock             $ 7,719          
Issuance of convertible preferred stock for cash, net of issuance costs (in shares)             21,614,220          
Issuance of convertible preferred stock for cash, net of issuance costs             $ 67,073          
Ending balance (in shares) at Dec. 31, 2019             94,818,151 0        
Ending balance at Dec. 31, 2019             $ 244,743 $ 0        
Beginning balance (in shares) at Dec. 31, 2018   26,206,837                    
Beginning balance at Dec. 31, 2018 $ (124,667) $ 3 $ 2,802 $ 0   $ (127,485)       $ 13   $ 0
Beginning balance (in shares) at Dec. 31, 2018                   134,337,450   0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Shares repurchased 0                      
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)                   3,612,062    
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants 4,925   4,924             $ 1    
Issuance of restricted common stock (in shares)                   1,686,378    
Issuance of restricted common stock 29   29                  
Share-based compensation 2,702   2,702                  
Other comprehensive (loss) income (1)     (1)                
Net loss (94,718)         (94,718)            
Ending balance (in shares) at Dec. 31, 2019   26,206,837                    
Ending balance at Dec. 31, 2019 (211,730) $ 3 10,457 (1)   (222,203)       $ 14   $ 0
Ending balance (in shares) at Dec. 31, 2019                   139,635,890   0
Increase (Decrease) in Temporary Equity [Roll Forward]                        
Issuance of convertible preferred stock for cash, net of issuance costs (in shares)               18,457,230        
Issuance of convertible preferred stock for cash, net of issuance costs               $ 178,074        
Merger recapitalization (in shares)             (94,818,151) (18,457,230)        
Merger recapitalization—Class A             $ (244,743) $ (178,074)        
Ending balance (in shares) at Dec. 31, 2020             0 0        
Ending balance at Dec. 31, 2020             $ 0 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Retirement of Class A shares (in shares)                   (6,629,372)    
Retirement of Class A shares (1)                 $ (1)    
Shares repurchased 0                      
Conversion of certain shares into Class B common stock (in shares)   (22,935,413)               (82,182,790)   105,118,203
Conversion of certain shares into Class B common stock 3,000 $ (3) 3,000             $ (8)   $ 11
Merger recapitalization—Class A (in shares)   (3,271,424)               116,546,805    
Merger recapitalization—Class A 422,814   422,802             $ 12    
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)                   1,466,155    
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants 30,112   30,112                  
Gores shares recapitalized, net of redemptions and equity issuance costs (in shares)                   49,981,349    
Gores shares recapitalized, net of redemptions and equity issuance costs of $17,226 363,460   363,455             $ 5    
Share-based compensation 5,745   5,745                  
Public and Private Warrants 102,396   102,396                  
Other comprehensive (loss) income 35     35                
Net loss (362,298)         (362,298)            
Ending balance (in shares) at Dec. 31, 2020   0                    
Ending balance at Dec. 31, 2020 148,741 $ 0 733,175 34   (584,501)       $ 22   $ 11
Ending balance (in shares) at Dec. 31, 2020                 218,818,037 218,818,037 105,118,203 105,118,203
Ending balance (in shares) at Dec. 31, 2021             0 0        
Ending balance at Dec. 31, 2021             $ 0 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Retirement of Class A shares (in shares)                   (71,894)    
Retirement of Class A shares 0                      
Purchases of capped call options related to the convertible senior notes (73,438)   (73,438)                  
Shares repurchased 4,273       $ (235,871)              
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)                   15,574,037    
Issuance of Class A common stock upon exercise of Public and Private Warrants 492,221   492,219             $ 2    
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in Shares)                   5,232,744    
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units 6,176   6,176             $ 0    
Vendor stock-in-lieu of cash program (in shares)                   291,940    
Vendor stock-in-lieu of cash program 10,743   10,743                  
Issuance of shares for investment in Robotic Research Opco, LLC (in shares)                   618,924    
Issuance of shares for investment in Robotic Research Opco, LLC 10,002   10,002                  
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants (in shares)                   15,000,000   (15,000,000)
Conversion of SAFE into Series A common stock and Issuance of Class A common stock upon exercise of warrants 0   0             $ 2   $ (2)
Gores shares recapitalized, net of redemptions and equity issuance costs (in shares)                   370,034    
Gores shares recapitalized, net of redemptions and equity issuance costs of $17,226 6,527   6,527                  
Issuance of earn-out shares (in shares)                   10,242,703   6,970,467
Issuance of earn-out shares 0   (2)             $ 1   $ 1
Share-based compensation 70,983   70,983                  
Public and Private Warrants 959                      
Payments of employee taxes related to vested restricted stock units (140)   (140)                  
Other comprehensive (loss) income (942)     (942)                
Net loss (237,986)         (237,986)            
Cash received from Gores on settlement of recapitalization of escrow $ 10   10                  
Ending balance (in shares) at Dec. 31, 2021 0 0                    
Ending balance at Dec. 31, 2021 $ 197,985 $ 0 $ 1,257,214 $ (908) $ (235,871) $ (822,487)       $ 27   $ 10
Ending balance (in shares) at Dec. 31, 2021                 250,812,764 266,076,525 97,088,670 97,088,670